ANEMOCYTE
Live / Registered — Registered — Section 71 accepted (as of 28 Feb 2025)
What this means for you
Registered since 06 Jun 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79188650
- Registration number
- 5215720
- Mark type
- Stylized text
- Filed
- 11 Sept 2015
- Published for opposition
- 21 Mar 2017
- Registered
- 06 Jun 2017
- Attorney of record
- Brian A. Tollefson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for use in human [ and veterinary ] medicine; chemical preparations for pharmaceutical or medical purposes, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, syringes, infusion bags, vials and pharmaceutical preparations for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; biological preparations for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; biological preparations for medical and pharmaceutical use for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; chemical preparations for pharmaceutical purposes, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; preparations for diagnostics for medical purposes; drugs, namely, recombinant therapeutic proteins, nucleic acids, peptides, cells, genes and tissues for medical and veterinary purposes; medicines for the treatment of disorders in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; organic products for medical use, namely, natural biomaterials for cell delivery or for augmentation of tissues for medical purposes; biological reagents for medical use; medicinal products based on cells and genes, namely, somatic cells, genetically modified cells, viral vectors, nucleic acids and engineered tissues; products for somatic cell therapy, namely, adult stem cells, t-cells, b-cells, nk cells, dendritic cells, monocytes, macrophages, adipocytes, keratinocytes, erythrocytes, platelets, products for gene therapy, namely, genetically modified cells, viral vectors, nucleic acids; tissue engineered products, namely, cells and tissues that have been subjected to extensive manipulation and are used with the aim to repair, replace or restore a lost or impaired tissue or function; products for regenerative medicine, namely, cells and tissues that have been subjected to extensive manipulation and are used with the aim to repair, replace, restore or promote the repair, replacement or regeneration of a lost or impaired tissue or function; products for personalized medicine made of autologous cells or proteins or nucleid acids derived from individual genomic sequences; preparations made up of cells for medical or clinical use; preparations made up of nucleic acids, namely, nucleic acid sequences and chemical reagents for medical purposes; preparations made up of tissues, namely, biological tissue cultures for medical purposes; vaccines; recombinant proteins supplements; therapeutic kits consisting of therapeutic antibodies, buffers, and reagents for use in disease treatment and therapy
- Class 010 — Medical apparatus: [ Surgical apparatus and instruments for medical, dental and veterinary use; medical devices for the introduction of pharmaceutical preparations in the human body, in particular syringes and catheters; medical equipment, namely, centrifuges or other separation devices for the isolation of cell sub-populations from tissues and biopsies; surgical apparatus and instruments for medical and veterinary purpose; electrical medical instruments for use in electroporation of cells and tissues for gene transfer purposes, both in vivo and ex-vivo; electronic medical instruments for use in imaging for diagnostic purposes or for monitoring of vital signs of patients ]
- Class 042 — Scientific and technological services: Services of laboratory analysis and industrial research in the medical and pharmaceutical fields; research and development in the pharmaceutical and biotechnology fields; research and development in the field of micro-organisms and cells; research and development in biochemistry; scientific research and development in biology; research and development in the field of diagnostic preparations; services of medical laboratories; Providing medical and scientific research information and data on developments in the medical and veterinary fields; scientific and technological services, namely, scientific research in the field of cancer, immunology, heart and lung conditions, infectious diseases, ophthalmology, genito-urinary, central nervous system, musco-skeletal, metabolic diseases, dermatology; consultancy to ensure compliance with quality standards and the design and validation of manufacturing processes in the scientific field and medical technology fields
Owner
- ANEMOCYTE S.R.L., GERENZANO (VA), IT
- ARETA INTERNATIONAL S.R.L., IT
- ARETA INTERNATIONAL S.R.L., IT
Prosecution history
- 26 Mar 2026 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 28 Oct 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 30 Sept 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 03 Jul 2025 — INTERNATIONAL REGISTRATION RENEWED
- 28 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 28 Feb 2025 — REGISTERED-SEC.71 ACCEPTED
- 15 Nov 2024 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 25 Oct 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 21 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 24 Feb 2024 — POST REGISTRATION ACTION MAILED - SEC.71
- 12 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Jun 2023 — TEAS SECTION 71 RECEIVED
- 24 Oct 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Oct 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Oct 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS